Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Bibliographic Details
Main Authors: Go, Se‐Il, Park, Mi Jung, Song, Haa‐Na, Kim, Hoon‐Gu, Kang, Myoung Hee, Lee, Hyang Rae, Kim, Yire, Kim, Rock Bum, Lee, Soon Il, Lee, Gyeong‐Won
Format: Online
Language:English
Published: John Wiley and Sons Inc. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833756/
id pubmed-4833756
recordtype oai_dc
spelling pubmed-48337562016-04-21 Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone Go, Se‐Il Park, Mi Jung Song, Haa‐Na Kim, Hoon‐Gu Kang, Myoung Hee Lee, Hyang Rae Kim, Yire Kim, Rock Bum Lee, Soon Il Lee, Gyeong‐Won Original Articles John Wiley and Sons Inc. 2016-04-12 2016-12 /pmc/articles/PMC4833756/ /pubmed/27104110 http://dx.doi.org/10.1002/jcsm.12115 Text en © 2016 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society of Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Go, Se‐Il
Park, Mi Jung
Song, Haa‐Na
Kim, Hoon‐Gu
Kang, Myoung Hee
Lee, Hyang Rae
Kim, Yire
Kim, Rock Bum
Lee, Soon Il
Lee, Gyeong‐Won
spellingShingle Go, Se‐Il
Park, Mi Jung
Song, Haa‐Na
Kim, Hoon‐Gu
Kang, Myoung Hee
Lee, Hyang Rae
Kim, Yire
Kim, Rock Bum
Lee, Soon Il
Lee, Gyeong‐Won
Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
author_facet Go, Se‐Il
Park, Mi Jung
Song, Haa‐Na
Kim, Hoon‐Gu
Kang, Myoung Hee
Lee, Hyang Rae
Kim, Yire
Kim, Rock Bum
Lee, Soon Il
Lee, Gyeong‐Won
author_sort Go, Se‐Il
title Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
title_short Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
title_full Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
title_fullStr Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
title_full_unstemmed Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
title_sort prognostic impact of sarcopenia in patients with diffuse large b‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
description
publisher John Wiley and Sons Inc.
publishDate 2016
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833756/
_version_ 1613567005846142976

Similar Items